Journal of Controlled Release · 2020 · 14 citations · 42 references
PharmacyBiochemistryBiophysicsBiophotonicsDrug DeliveryNanomaterialsLipid-based NanoparticlesLiposome-based DeliveryNanomaterials For Drug DeliveryNanomedicineNanoparticle Delivery SystemsPeptide DeliveryBiomolecule-nanoparticle InteractionsLight-triggered ReleaseLiposomesNoble Metal NanoclustersPeptide NanoparticlesPeptide-functionalized NanomaterialsThermodynamics Of NanoclustersThermosensitive Liposomes
Angiotensin-(1-9), a component of the non-canonical renin-angiotensin system, has a short half-life in blood. This peptide has shown to prevent and/or attenuate hypertension and cardiovascular remodeling. A controlled release of angiotensin-(1-9) is needed for its delivery to the heart. Our aim was to develop a drug delivery system for angiotensin-(1-9). Thermosensitive liposomes (LipoTherm) were prepared with gold nanoclusters (LipoTherm-AuNC) to increase the stability and reach a temporal and spatial control of angiotensin-(1-9) release. Encapsulation efficiencies of nearly 50% were achieved in LipoTherm, reaching a total angiotensin-(1-9) loading of around 180 μM. This angiotensin-(1-9)-loaded LipoTherm sized around 100 nm and exhibited a phase transition temperature of 43 °C. AuNC were grown on LipoTherm and the new hybrid nanosystem showed energy absorption in the near-infrared (NIR) wavelength range. By NIR laser irradiation, a controlled release of angiotensin-(1-9) was achieved from the LipoTherm-AuNC nanosystem. These nanosystems did not show any cytotoxic effect on cultured cardiomyocytes. Biological activity of angiotensin-(1-9) released from the LipoTherm-AuNC-based nanosystem was confirmed using an ex vivo Langendorff heart model.
42
Renal clearance of quantum dots
Hak Soo Choi, Wenhao Liu, Preeti Misra et al. · Nature Biotechnology · 2007 · 4.4K citations · Full text
Jeffrey K. Mills, David Needham · Biochimica et Biophysica Acta (BBA) - Biomembranes · 2005 · 235 citations